Navigation Links
Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
Date:1/8/2009

Current and Emerging Drugs Will Not Surpass Vyvanse as the Clinical Gold Standard, According to a New Report From Decision Resources

WALTHAM, Mass., Jan. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that physicians indicate there is an unmet need for a safe and effective nonstimulant therapy approved for adult attention-deficit/hyperactivity disorder (ADHD) with no risk of suicidal ideation. Such a drug has potential to earn a 25 percent patient share of the drug treated adult ADHD population, according to surveyed U.S. psychiatrists. In contrast, in Europe, such an agent would earn a markedly higher patient share of 40 percent, according to surveyed European psychiatrists.

This difference in patient share likely reflects U.S. physicians' reasonably high level of satisfaction with currently-available psychostimulants, with which they have decades of clinical experience, despite their disadvantages of abuse-liability and prescribing restrictions. Conversely, European physicians have to contend with greater prescribing restrictions, fewer treatment options, and are more averse to stimulants' risk of abuse than their U.S. counterparts. As a result, physicians would greatly welcome a safer and more effective nonstimulant alternative to Eli Lilly's Strattera as a first-line therapy for adult ADHD.

The new report entitled Attention-Deficit/Hyperactivity Disorder: Emerging Therapies Fall Short of Physicians' Expectations for Safer and More-Effective Nonstimulants finds that current and emerging drugs have not yet demonstrated substantial clinical advantages over Shire's Vyvanse, Decision Resources' 2008 clinical gold standard in the treatment of ADHD. According to interviewed physicians, none of the emerging therapies represent a major innovation in ADHD treatment or offer an overwhelmingly prefera
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Renal Physicians Association 2009 Annual Meeting
2. Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians
3. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
4. Aurora Physicians Receive National Recognition for Quality Diabetes Care
5. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
6. Supply of board-certified emergency physicians unlikely to meet projected needs
7. Dr. Steven Liu, Founder of Ingenious Med, Recognized as a Leading Hospitalist by the American College of Physicians
8. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
9. Medscape Physician Connect Becomes Largest Online Physician Social Network with More than 100,000 Physicians
10. Scientists, Physicians, Health, and Environmental Justice Advocates to New Obama EPA Director: We Look Forward to Toxic Chemical Regulatory Reform
11. Anti-Aging Miracle Physicians Have Been Waiting for is Finally Here : Free Book Available From Natural Health News Report Reveals the Secret to Staying Young

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ire/ -- Speaker Nancy Pelosi and Democratic leader...age of H.R. 3962, the Affordable Health Care for A...15. Below are the Speaker,s opening remarks: ,...ll from the President of the United States, Barack...he American people. I thank the President for his ...
(Date:11/8/2009)...s is pleased to announce that it has been successf...ound who recently received an award on the $800 mi...ncludes not only the Veterans Administration, but ...gencies. , New York, NY (...pleased to announce that it has been successful in...
(Date:11/8/2009)... in the Western District of Pennsylvania award a F...ng for a medical malpractice case. Attorneys Thom...mas E. Crenney and Associates, LLC handled the cas... against the Uniontown Hospital. The woman had to... age 18. , Pittsburgh, PA...
(Date:11/8/2009)...health advocates committed to achieving meaningful.... 7 "Tonight the U.S. H... voice of America,s families by passing the Afford...ust deliver, without delay, on the promise of mean...do, President and CEO of the National Alliance for...
(Date:11/8/2009)...to Secure the Stability of Medicare ,, HOUSTON...ibutable to: J. James Rohack, M.D., President, Ame...ww.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...h reform bill, which will help improve the health ...wift passage of H.R. 3961 to secure the stability ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... ‘present’ - the common cause of amnesia, also pre...ing them to live only in the present. Researc...f Proceedings of the National Academy of Sciences ...rucial in learning and memory. Though, it has...
...bout having a child, it’s a research they will bac...ospital plan the first uterus transplant with the ...medical adventure is not without ethical controve...ient gives birth so she would not need anti-reject...
...alia health providers is busy counting its losses....ve had their doctors resort to rorting or over ser...procedures that were not necessary. The loss in...s at inappropriate practices such as over-servicin...
...rge family may not be best for your health. A new ...e development of stomach cancer linked to the bact...from large families appeared to be especially vuln...re followed over a 28-year period. The researchers...
...d a structural protein called nestin to a particul...ew biomarker that could lead to earlier detection ...sue of Cancer Research, researchers from Dartmouth...ith similarities to mammary stem cells, the regene...
...ening of adults age 50 or older appears to be as c...er screening programs, according to an article in ... Melanoma is the only cancer for which incidence...cle. Treating melanoma costs more than $740 millio...
Other Medicine News:Health News:Amnesia Halts Future Thinking: Study 2Health News:Uterus Transplant- A Future Reality 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:One-time Melanoma Screening Appears to Be Cost-effective for Elderly People 2
(Date:11/6/2009)...re/ -- Facet Solutions, Inc. announced today that ...edics. The acquisition creates an undisputed leade...property and clinical experience in posterior moti...ring from lumbar spinal stenosis," stated Facet So...consolidation further strengthens Facet Solutions,...
(Date:11/6/2009)...re/ -- Philips Respironics applauds the efforts of...DC) to raise awareness about an important public h...C,s release of the first-ever government study to ...s is a milestone in quantifying the size and scope...ndustry leader and sleep therapy manufacturer, Phi...
(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 1Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 1Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 3
...ed Alone and in Combination with Chemotherapy, FR..., a,development-stage pharmaceutical company disco...)-based therapeutics, today announced that the,jou... of siRNA targeting,its proprietary target gene ag...ition dated October 1, 2008. The paper, entitled "...
...ASHINGTON, Oct. 12 Boston,Scientific Corporation ...ysis,of nearly 7,500 patients from its TAXUS ARRIV...m the performance of the TAXUS(R) Express2(TM),Pac...d practice. The,two-year pooled ARRIVE data showed...in patients with diabetes as effectively as in pat...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5
OHL Periosteal Elevator
Steinhauser Periosteal Elevator
Dolwick-Reich Condyle Periosteal Elevator
Molt Periosteal Elevator
Medicine Products: